UK Lupus Market – Biologics and Novel Therapies Transforming Care
Market OverviewBiologics and novel therapies are transforming the UK lupus market, offering targeted treatment options for patients with inadequate responses to conventional immunosuppressants. Belimumab and anifrolumab represent significant advances, reducing disease activity and steroid dependence. The market is projected to grow through 2030, fueled by clinical research and expanded NHS...
0 Comments 0 Shares 7 Views 0 Reviews
SocioMint https://sociomint.com